Dr. Habib Skaff is a synthetic chemist specializing in the area of nanotechnology. He currently serves as Managing Partner of Cedar Capital Holdings, LLC, where he heads operations as well as acquisitions of companies in fields from wound care to recycling. Until 2016, Dr. Skaff served as Chief Executive Officer of Intezyne Technologies, which he co-founded in 2004.
Dr. Skaff received a Ph.D. in Polymer Science and Engineering from the University of Massachusetts, Amherst. His doctoral studies involved the design of organic and polymeric ligands for the encapsulation of semiconductor nanoparticles and modification of the physical, optical, electronic, and assembly properties of the nanoparticles. He also earned a M.S. in Polymer Science and Engineering from the University of Massachusetts and a B.S. degree in Materials Science and Engineering (Honors) from the University of Florida. He has co-authored 11 peer-reviewed scientific papers and is a co-inventor on 18 pending or issued patents in the fields of chemistry, nanotechnology, and biotechnology.